CBD and Blood Pressure Medications: The Complete Interaction Guide | PureCraft CBD

⚠ Important | If you are currently taking blood pressure medication, discuss adding CBD with your prescribing physician or cardiologist before starting. Do not adjust your blood pressure medication dose without medical guidance. CBD has both direct vasodilatory effects and CYP enzyme interactions relevant to cardiovascular medications. PureCraft CBD products are broad-spectrum zero-THC, batch-verified at purecraftcbd.com/pages/faq.

By the PureCraft CBD Editorial Team  |  Updated 2026  |  12 min read

Two Mechanisms, One Cardiovascular System

High blood pressure (hypertension) affects nearly half of American adults, making antihypertensive medications among the most commonly prescribed drugs in the country. The interaction between CBD and blood pressure medications is more complex than most drug interaction guides acknowledge — because CBD affects blood pressure through two distinct routes: direct vasodilation via endocannabinoid signaling, and indirect effects through CYP enzyme inhibition that alters medication blood levels.

Understanding both mechanisms — and which specific medications are affected by each — is essential for anyone managing hypertension who wants to use CBD responsibly.

How CBD Affects Blood Pressure: The Direct Mechanism

CBD as a Direct Vasodilator

CBD produces direct vasodilation — relaxation of vascular smooth muscle and widening of blood vessels — through multiple mechanisms: CB1 receptor activation on vascular endothelium, TRPV1-mediated endothelium-dependent relaxation, and increased nitric oxide bioavailability. The clinical significance of this vasodilatory effect has been documented in human studies. The landmark Shannon et al. (2017) single-dose RCT found that a single 600mg dose of CBD reduced resting systolic blood pressure by 6 mmHg and attenuated the stress-induced blood pressure rise in healthy volunteers. At more typical supplement doses (15–25mg), the blood pressure effect is considerably more modest — but it is real and additive to antihypertensive medications.

This direct vasodilatory effect is the most clinically relevant CBD-blood pressure interaction — more practically significant than the CYP enzyme interactions for most patients on standard antihypertensive doses. The concern: CBD added on top of blood pressure medication may produce additive blood pressure lowering, potentially causing hypotension (dizziness, lightheadedness, fainting) particularly when standing (orthostatic hypotension).

HPA Recalibration and Chronic BP Reduction

CBD's progressive HPA axis recalibration — reducing chronic cortisol burden over 4–6 weeks — provides a second, slower-developing blood pressure benefit. Cortisol promotes sodium retention, peripheral vasoconstriction, and sympathetic nervous system activation, all of which raise blood pressure. Reducing chronic HPA-driven cortisol elevation contributes to lower sustained blood pressure over time. This mechanism is complementary to antihypertensive medications rather than directly interactive — but it means CBD's blood pressure effect develops in two phases: an early direct vasodilatory effect, and a slower cumulative HPA-mediated reduction.

CBD and Specific Blood Pressure Medication Classes

ACE Inhibitors: Lisinopril, Ramipril, Enalapril

ACE inhibitors (angiotensin-converting enzyme inhibitors) reduce blood pressure by blocking the conversion of angiotensin I to angiotensin II — preventing vasoconstriction and aldosterone release. They are among the most commonly prescribed antihypertensives.

CYP interaction: ACE inhibitors are not primarily metabolized by CYP2D6 or CYP3A4 — most are hydrolyzed by esterases rather than CYP enzymes. Lisinopril, the most widely prescribed ACE inhibitor, is not metabolized by the liver at all (excreted unchanged in urine). This makes ACE inhibitors the lowest CYP interaction risk antihypertensive class with CBD.

Additive hypotension risk: Still present. CBD's direct vasodilation adds to ACE inhibitor blood pressure lowering. Monitor for dizziness, particularly when rising from sitting or lying positions. The additive effect at typical CBD supplement doses is mild but worth monitoring, particularly in the first 1–2 weeks after starting CBD.

ARBs: Losartan, Valsartan, Olmesartan

Angiotensin receptor blockers (ARBs) block the AT1 receptor directly rather than preventing angiotensin II formation. They have a more variable CYP profile than ACE inhibitors.

CYP interaction: Losartan (Cozaar) is converted to its active metabolite by CYP2C9 — not a primary CBD inhibition target, so the pharmacokinetic interaction is low. Valsartan is minimally metabolized. Olmesartan is converted by CYP3A4 — CBD's CYP3A4 inhibition is relevant here, potentially raising olmesartan levels modestly.

Additive hypotension: Same as ACE inhibitors — present but mild at supplement CBD doses. Disclose to prescriber.

Beta-Blockers: Metoprolol, Atenolol, Carvedilol, Propranolol

Beta-blockers reduce heart rate and cardiac output by blocking beta-adrenergic receptors. They are prescribed for hypertension, heart failure, arrhythmias, and anxiety (propranolol for performance anxiety).

CYP interaction: This is where the CYP interaction becomes clinically most relevant in the antihypertensive class. Metoprolol and carvedilol are CYP2D6 substrates — CBD's CYP2D6 inhibition can raise their blood levels, potentially intensifying beta-blockade: lower heart rate, reduced cardiac output, fatigue, and cold extremities. Propranolol is also a CYP2D6 substrate and additionally inhibits CYP2D6 itself — bidirectional interaction. Atenolol is not CYP-metabolized (renal excretion) — lowest interaction risk in the class.

Additive hypotension and bradycardia: CBD's vasodilation combined with beta-blocker blood pressure and heart rate reduction creates the most significant additive cardiovascular risk in the antihypertensive class. Elevated metoprolol or carvedilol levels from CYP2D6 inhibition, on top of direct CBD vasodilation, can produce meaningful hypotension and bradycardia at doses that were previously well tolerated. Prescriber discussion is particularly important here — this combination requires monitoring, not just disclosure.

Calcium Channel Blockers: Amlodipine, Diltiazem, Verapamil, Nifedipine

Calcium channel blockers (CCBs) reduce blood pressure by relaxing vascular smooth muscle through calcium channel inhibition. They are divided into dihydropyridines (amlodipine, nifedipine — primarily vascular) and non-dihydropyridines (diltiazem, verapamil — also affect heart rate).

CYP interaction: All major CCBs are CYP3A4 substrates — and CBD is a CYP3A4 inhibitor. This is the most consistent CYP interaction in the antihypertensive class. CBD can raise amlodipine, diltiazem, verapamil, and nifedipine levels — with amlodipine being the most commonly prescribed and therefore most practically relevant. Additionally, diltiazem and verapamil are themselves CYP3A4 inhibitors — creating a bidirectional interaction where each drug raises the other's levels.

Practical significance: Elevated CCB levels increase vasodilation, potentially producing hypotension, peripheral edema, and reflex tachycardia. For diltiazem and verapamil, elevated levels also affect cardiac conduction — slowing heart rate more than intended. This combination warrants explicit prescriber guidance and possibly blood pressure monitoring at home when CBD is first added.

Diuretics: Hydrochlorothiazide, Furosemide, Spironolactone

Diuretics reduce blood pressure by promoting sodium and water excretion, reducing blood volume. They are often prescribed as first-line hypertension treatment or in combination with other antihypertensives.

CYP interaction: Most diuretics have minimal CYP metabolism — hydrochlorothiazide and furosemide are renally excreted without significant CYP involvement. Spironolactone has some CYP3A4 metabolism but the interaction at supplement CBD doses is considered low.

Additive hypotension: Present — CBD's vasodilation adds to the volume-depleting blood pressure effect of diuretics. Orthostatic hypotension (dizziness on standing) is the most practical concern, particularly in older adults already prone to volume depletion. Hydration and rising slowly mitigate this risk.

The two CBD-blood pressure interactions that require the most prescriber attention: calcium channel blockers (CYP3A4 — all major CCBs affected) and beta-blockers (CYP2D6 — metoprolol, carvedilol, propranolol). Both have additive hypotension risk on top of the pharmacokinetic interaction.

Blood Pressure Medication Interaction Summary

Practical Guidance: Starting CBD Safely With Blood Pressure Medications

If your prescriber approves adding CBD alongside blood pressure medication, several practical steps reduce risk:

• Start low: Begin at 10–15mg CBD Oil rather than a higher starting dose, to assess how your blood pressure responds before increasing.
• Monitor blood pressure at home: Take blood pressure readings daily for the first 2 weeks after starting CBD. Note any readings below your typical baseline or any symptoms of hypotension (dizziness, lightheadedness, fainting when standing).
• Rise slowly: Orthostatic hypotension (blood pressure drop on standing) is the most common practical risk. Rising slowly from sitting or lying positions gives the cardiovascular system time to compensate.
• Time CBD away from medication doses when possible: Taking CBD and antihypertensives at different times of day reduces peak plasma level overlap, though it does not eliminate the CYP interaction.
• Report changes to your prescriber: Any new dizziness, unexpectedly low blood pressure readings, or unusual fatigue should prompt a conversation with your prescriber — these could indicate additive hypotension or elevated medication levels from CYP inhibition.

Does CBD Help Lower Blood Pressure?

This is a question many people with hypertension ask — and the evidence is more nuanced than CBD marketing often implies. A single dose of high-dose CBD (600mg in the Shannon 2017 trial) did produce a statistically significant reduction in resting and stress-induced blood pressure. At supplement doses (15–25mg), the direct blood pressure effect is considerably more modest. CBD's progressive HPA recalibration — reducing the cortisol and sympathetic nervous system contribution to blood pressure over 4–6 weeks — likely contributes a small additional reduction in those whose hypertension has a significant stress component.

The honest assessment: CBD is not a blood pressure medication and should not be used as a substitute for prescribed antihypertensives. For people whose hypertension is partly stress-driven, CBD's HPA mechanism may contribute modest complementary benefit — but this should be monitored in partnership with a prescriber, not self-managed.

Frequently Asked Questions

Can I take CBD with lisinopril?

Lisinopril has the lowest interaction risk of the major antihypertensives — it is not hepatically metabolized, so the CYP2D6/3A4 inhibition from CBD is not relevant. The remaining concern is additive vasodilation: CBD's direct blood pressure lowering effect adds to lisinopril's. For most people at typical supplement CBD doses, this additive effect is mild. Disclose to your prescriber, monitor for dizziness particularly on standing, and start at a lower CBD dose (10–15mg) to assess tolerance before increasing.

Can I take CBD with metoprolol?

Metoprolol is a CYP2D6 substrate — CBD's CYP2D6 inhibition can raise metoprolol blood levels, potentially intensifying beta-blockade (lower heart rate, fatigue, cold extremities, more pronounced blood pressure reduction). Combined with CBD's direct vasodilation, the additive cardiovascular effect is more significant than with ACE inhibitors or diuretics. This combination warrants explicit prescriber discussion and home blood pressure and heart rate monitoring when starting CBD. Do not start CBD with metoprolol without your cardiologist's knowledge.

Can I take CBD with amlodipine?

Amlodipine is a CYP3A4 substrate — CBD can raise amlodipine levels through CYP3A4 inhibition, potentially intensifying vasodilation and increasing the risk of peripheral edema and hypotension. Amlodipine has a long half-life (30–50 hours), which means level changes from CYP inhibition develop slowly and persist. This combination is manageable with prescriber oversight but requires disclosure and monitoring — particularly for new or worsening ankle swelling, dizziness, or unusually low blood pressure readings.

Will CBD lower my blood pressure too much?

At typical supplement doses (15–25mg), CBD's direct blood pressure effect is modest — estimated at a few mmHg at most in most individuals. The more significant risk is additive hypotension when combined with antihypertensive medications, particularly calcium channel blockers and beta-blockers where CYP inhibition also raises medication levels. Symptoms of excessive blood pressure lowering include dizziness on standing, lightheadedness, fainting, or an unusually low home blood pressure reading. If these occur, contact your prescriber — do not adjust medication doses yourself.

Which blood pressure medication has the lowest CBD interaction risk?

ACE inhibitors — particularly lisinopril and ramipril — have the lowest interaction risk because they are not significantly metabolized by CYP2D6 or CYP3A4. Atenolol and bisoprolol in the beta-blocker class are also lower risk for the same reason. Hydrochlorothiazide among diuretics is similarly low-CYP. The highest interaction risk classes are calcium channel blockers (all CYP3A4 substrates) and CYP2D6-metabolized beta-blockers (metoprolol, carvedilol, propranolol).

Can CBD replace my blood pressure medication?

No — CBD is not a blood pressure medication and should not replace prescribed antihypertensives. Uncontrolled hypertension significantly increases risk of stroke, heart attack, and kidney disease. CBD's modest blood pressure effects at supplement doses are not a substitute for medication that has been prescribed for a clinical indication. If you are interested in reducing your antihypertensive medication, that conversation needs to happen with your cardiologist based on clinical blood pressure data — not on the basis of adding CBD.

The Bottom Line

CBD and blood pressure medications interact through two mechanisms that both require prescriber awareness: direct additive vasodilation (relevant for all antihypertensive classes) and CYP enzyme-mediated medication level elevation (most significant for calcium channel blockers and CYP2D6-metabolized beta-blockers). The combination is manageable with proper disclosure and monitoring — not categorically contraindicated. Start low, monitor blood pressure at home, rise slowly, and report any symptoms of hypotension to your prescriber. ACE inhibitors represent the lowest overall interaction risk; calcium channel blockers and metoprolol/carvedilol require the most careful monitoring.

PureCraft CBD Oil — start at 10–15mg daily if on blood pressure medication. Zero THC, batch-tested COA. Browse all PureCraft CBD products.

Medical Disclaimer | Do not adjust your blood pressure medication based on information in this guide. CBD is not a substitute for prescribed antihypertensive therapy. Disclose CBD use to your cardiologist or prescriber before starting. PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease.